ID ES8 AC CVCL_1204 SY ES-8 DR CLO; CLO_0009865 DR ArrayExpress; E-MTAB-783 DR ArrayExpress; E-MTAB-3610 DR BioGRID_ORCS_Cell_line; 888 DR cancercelllines; CVCL_1204 DR Cell_Model_Passport; SIDM00261 DR ChEMBL-Cells; CHEMBL3308153 DR ChEMBL-Targets; CHEMBL2366069 DR Cosmic; 684060 DR Cosmic; 949155 DR Cosmic; 1995399 DR Cosmic; 2060799 DR Cosmic; 2228227 DR Cosmic-CLP; 949155 DR DepMap; ACH-002109 DR EGA; EGAS00001000978 DR GDSC; 949155 DR GEO; GSM1669775 DR GEO; GSM1676297 DR GEO; GSM1701632 DR IARC_TP53; 27160 DR LINCS_LDP; LCL-1445 DR PharmacoDB; ES8_344_2019 DR PRIDE; PXD030304 DR PubChem_Cell_line; CVCL_1204 DR Wikidata; Q54832645 RX PubMed=20164919; RX PubMed=25010205; RX PubMed=26351324; RX PubMed=27397505; RX PubMed=30894373; RX PubMed=30971826; RX PubMed=34413129; RX PubMed=35839778; CC Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). CC Part of: COSMIC cell lines project. CC Population: Caucasian. CC Microsatellite instability: Stable (MSS) (Sanger). CC Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=25010205). CC Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 2 fusion (Ex7/Ex5) (PubMed=25010205). CC Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Phe (c.404G>T); ClinVar=VCV000376559; Zygosity=Homozygous (PubMed=25010205; Cosmic-CLP=949155). CC Omics: Genomics; DNA methylation analysis. CC Omics: Genomics; Whole exome sequencing. CC Omics: Phenotyping; CRISPR screening. CC Omics: Phenotyping; Drug screening. CC Omics: Proteomics; Quantitative. CC Omics: Transcriptomics; Microarray. CC Omics: Transcriptomics; RNAseq. CC Omics: Variations; SNP array analysis. CC Genome ancestry: African=1.48%; Native American=0.07%; East Asian, North=0.25%; East Asian, South=1.89%; South Asian=9.11%; European, North=26.16%; European, South=61.04% (PubMed=30894373). ST Source(s): Cosmic-CLP=949155; PubMed=25010205 ST Amelogenin: X,Y ST CSF1PO: 10,13 ST D13S317: 13 ST D16S539: 11 ST D18S51: 15,17 ST D19S433: 13,14 ST D21S11: 29,33.2 ST D2S1338: 18 ST D3S1358: 16 ST D5S818: 12,13 ST D7S820: 7,12 ST D8S1179: 12,14 ST FGA: 18,23 ST TH01: 6,9.3 ST TPOX: 8,9 ST vWA: 16,17 DI NCIt; C4817; Ewing sarcoma DI ORDO; Orphanet_319; Ewing sarcoma OX NCBI_TaxID=9606; ! Homo sapiens (Human) SX Male AG 10Y CA Cancer cell line DT Created: 04-04-12; Last updated: 10-04-25; Version: 38 CH CVCL_C6N6 ! ES8-SLFN11-KO // RX PubMed=35839778; DOI=10.1016/j.ccell.2022.06.010; PMCID=PMC9387775; RA Goncalves, Emanuel RA Poulos, Rebecca C. RA Cai, Zhao-Xiang RA Barthorpe, Syd RA Manda, Srikanth S. RA Lucas, Natasha RA Beck, Alexandra RA Bucio-Noble, Daniel RA Dausmann, Michael RA Hall, Caitlin RA Hecker, Michael RA Koh, Jennifer RA Lightfoot, Howard RA Mahboob, Sadia RA Mali, Iman RA Morris, James RA Richardson, Laura RA Seneviratne, Akila J. RA Shepherd, Rebecca RA Sykes, Erin RA Thomas, Frances RA Valentini, Sara RA Williams, Steven G. RA Wu, Yang-Xiu RA Xavier, Dylan RA MacKenzie, Karen L. RA Hains, Peter G. RA Tully, Brett RA Robinson, Phillip James RA Zhong, Qing RA Garnett, Mathew J. RA Reddel, Roger Robert RT "Pan-cancer proteomic map of 949 human cell lines."; RL Cancer Cell 40:835-849.e8(2022). // RX PubMed=25010205; DOI=10.1371/journal.pgen.1004475; PMCID=PMC4091782; RA Brohl, Andrew S. RA Solomon, David A. RA Chang, Wendy RA Wang, Jian-Jun RA Song, Young RA Sindiri, Sivasish RA Patidar, Rajesh RA Hurd, Laura RA Chen, Li RA Shern, Jack F. RA Liao, Hong-Ling RA Wen, Xin-Yu RA Gerard, Julia RA Kim, Jung-Sik RA Lopez-Guerrero, Jose Antonio RA Machado, Isidro RA Wai, Daniel H. RA Picci, Piero RA Triche, Timothy J. RA Horvai, Andrew E. RA Miettinen, Markku Martti RA Wei, Jun S. RA Catchpoole, Daniel RA Llombart-Bosch, Antonio RA Waldman, Todd A. RA Khan, Javed RT "The genomic landscape of the Ewing sarcoma family of tumors reveals RT recurrent STAG2 mutation."; RL PLoS Genet. 10:e1004475.1-e1004475.13(2014). // RX PubMed=26351324; DOI=10.1158/1535-7163.MCT-15-0074; PMCID=PMC4636476; RA Teicher, Beverly A. RA Polley, Eric C. RA Kunkel, Mark W. RA Evans, David RA Silvers, Thomas E. RA Delosh, Rene M. RA Laudeman, Julie RA Ogle, Chad RA Reinhart, Russell RA Selby, Michael RA Connelly, John RA Harris, Erik RA Monks, Anne RA Morris, Joel RT "Sarcoma cell line screen of oncology drugs and investigational agents RT identifies patterns associated with gene and microRNA expression."; RL Mol. Cancer Ther. 14:2452-2462(2015). // RX PubMed=27397505; DOI=10.1016/j.cell.2016.06.017; PMCID=PMC4967469; RA Iorio, Francesco RA Knijnenburg, Theo A. RA Vis, Daniel J. RA Bignell, Graham Robert RA Menden, Michael Patrick RA Schubert, Michael RA Aben, Nanne RA Goncalves, Emanuel RA Barthorpe, Syd RA Lightfoot, Howard RA Cokelaer, Thomas RA Greninger, Patricia RA van Dyk, Ewald RA Chang, Han RA de Silva, Heshani RA Heyn, Holger RA Deng, Xian-Ming RA Egan, Regina K. RA Liu, Qing-Song RA Mironenko, Tatiana RA Mitropoulos, Xeni RA Richardson, Laura RA Wang, Jin-Hua RA Zhang, Ting-Hu RA Moran, Sebastian RA Sayols, Sergi RA Soleimani, Maryam RA Tamborero, David RA Lopez-Bigas, Nuria RA Ross-Macdonald, Petra RA Esteller, Manel RA Gray, Nathanael S. RA Haber, Daniel Arie RA Stratton, Michael Rudolf RA Benes, Cyril Henri RA Wessels, Lodewyk F.A. RA Saez-Rodriguez, Julio RA McDermott, Ultan RA Garnett, Mathew J. RT "A landscape of pharmacogenomic interactions in cancer."; RL Cell 166:740-754(2016). // RX PubMed=34413129; DOI=10.1158/1535-7163.MCT-21-0089; PMCID=PMC8571037; RA Gartrell, Jessica RA Mellado-Largarde, Marcia RA Clay, Michael R. RA Bahrami, Armita RA Sahr, Natasha A. RA Sykes, April D. RA Blankenship, Kaley RA Hoffmann, Lauren RA Xie, Jia RA Cho, Hyekyung P. RA Twarog, Nathaniel RA Connelly, Michele RA Yan, Koon-Kiu RA Yu, Ji-Yang RA Porter, Shaina N. RA Pruett-Miller, Shondra M. RA Neale, Geoffrey RA Tinkle, Christopher L. RA Federico, Sara M. RA Stewart, Elizabeth A. RA Shelat, Anang A. RT "SLFN11 is widely expressed in pediatric sarcoma and induces variable RT sensitization to replicative stress caused by DNA-damaging agents."; RL Mol. Cancer Ther. 20:2151-2165(2021). // RX PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747; PMCID=PMC6445675; RA Dutil, Julie RA Chen, Zhi-Hua RA Monteiro, Alvaro N.A. RA Teer, Jamie K. RA Eschrich, Steven A. RT "An interactive resource to probe genetic diversity and estimated RT ancestry in cancer cell lines."; RL Cancer Res. 79:1263-1273(2019). // RX PubMed=20164919; DOI=10.1038/nature08768; PMCID=PMC3145113; RA Bignell, Graham Robert RA Greenman, Christopher D. RA Davies, Helen R. RA Butler, Adam P. RA Edkins, Sarah RA Andrews, Jenny M. RA Buck, Gemma RA Chen, Lina RA Beare, David RA Latimer, Calli RA Widaa, Sara RA Hinton, Jonathan RA Fahey, Ciara RA Fu, Bei-Yuan RA Swamy, Sajani RA Dalgliesh, Gillian L. RA Teh, Bin Tean RA Deloukas, Panos RA Yang, Feng-Tang RA Campbell, Peter J. RA Futreal, P. Andrew RA Stratton, Michael Rudolf RT "Signatures of mutation and selection in the cancer genome."; RL Nature 463:893-898(2010). // RX PubMed=30971826; DOI=10.1038/s41586-019-1103-9; RA Behan, Fiona M. RA Iorio, Francesco RA Picco, Gabriele RA Goncalves, Emanuel RA Beaver, Charlotte M. RA Migliardi, Giorgia RA Santos, Rita RA Rao, Yanhua RA Sassi, Francesco RA Pinnelli, Marika RA Ansari, Rizwan RA Harper, Sarah RA Jackson, David Adam RA McRae, Rebecca RA Pooley, Rachel RA Wilkinson, Piers RA van der Meer, Dieudonne J. RA Dow, David RA Buser-Doepner, Carolyn A. RA Bertotti, Andrea RA Trusolino, Livio RA Stronach, Euan Alexander RA Saez-Rodriguez, Julio RA Yusa, Kosuke RA Garnett, Mathew J. RT "Prioritization of cancer therapeutic targets using CRISPR-Cas9 RT screens."; RL Nature 568:511-516(2019). //